2021

We are excited to announce the publication about Cyclomics’ core CyclomicsSeq technology in Genomic Medicine.  CyclomicsSeq technology involves a novel consensus sequencing approach fully optimised for circulating tumor DNA. The small size and low abundance of circulating tumor DNA in the blood of cancer patients makes accurate detection of cancer mutations difficult. Cyclomics has established a novel technology that enables efficient… Read More »Cyclomics announces publication on CyclomicsSeq technology

We are happy to announce the appointment of Dàmi Rebergen to strengthen the bioinformatics capabilities of Cyclomics. Dàmi Rebergen has a bioinformatics degree from Wageningen University (2019) and has recent experience working at startup and biotech companies in The Netherlands and the UK. At Cyclomics, Dàmi will perform a key role in the establishment of a user friendly bioinformatic analysis and… Read More »Appointment of Dàmi Rebergen as bioinformatician at Cyclomics